Theseus Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
THRX Nasdaq 8731 https://theseusrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Theseus Pharmaceuticals Inc

Theseus Pharmaceuticals to Participate in the Jefferies Healthcare Conference - May 31st, 2023 11:00 am
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST - May 25th, 2023 9:01 pm
Weekly biotech pulse: Sana, aTyr, Theseus to release fresh data - May 22nd, 2023 11:33 am
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results - May 11th, 2023 11:00 am
Here's Why We're Not Too Worried About Theseus Pharmaceuticals' (NASDAQ:THRX) Cash Burn Situation - May 2nd, 2023 2:25 pm
Theseus Pharmaceuticals Initial Dose Escalation Results from Ongoing Phase 1/2 Trial of THE-630 Accepted for Online Publication at 2023 ASCO Annual Meeting - Apr 26th, 2023 2:05 pm
Theseus Pharmaceuticals to Participate in Upcoming Investor Conferences - Apr 11th, 2023 11:00 am
Wall Street Analysts See a 128.83% Upside in Theseus Pharmaceuticals, Inc. (THRX): Can the Stock Really Move This High? - Apr 4th, 2023 1:55 pm
Theseus Pharmaceuticals to Participate in the Cantor Future of Oncology Virtual Symposium - Mar 28th, 2023 11:00 am
Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals - Mar 22nd, 2023 11:37 am
4 Biotech Stocks to Consider for Your Portfolio in 2023 - Mar 21st, 2023 3:32 pm
What Makes Theseus Pharmaceuticals, Inc. (THRX) a New Buy Stock - Mar 14th, 2023 4:00 pm
Painful week for private equity firms invested in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) after 13% drop, institutions also suffered losses - Mar 13th, 2023 10:41 am
Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 9th, 2023 12:00 pm
Theseus Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference - Feb 7th, 2023 12:00 pm
Theseus Pharmaceuticals Highlights Key Anticipated 2023 Milestones and Announces BCR-ABL as Target for Third Development Program - Jan 5th, 2023 12:00 pm
Investing in These 2 Biotech Stocks Could Double Your Money, Says Analyst - Dec 15th, 2022 1:24 am
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies - Dec 14th, 2022 6:20 pm
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third Quarter 2022 Financial Results - Nov 3rd, 2022 11:00 am
Theseus Pharmaceuticals Presents Preclinical Data Characterizing THE-349, its Fourth-Generation EGFR Inhibitor in Development for NSCLC, at the 34th EORTC-NCI-AACR Symposium - Oct 26th, 2022 11:00 am